← Open Payments lookup

TIFFANY TRAN: Open Payments

NPI 1922770551 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,759 in 129 payments from 16 companies in 2025. Trend: 2023 $2,148 · 2024 $2,259 · 2025 $2,759

Food & beverage: $2,759
CompanyPaymentsAmount
ABBVIE INC.27$511
Otsuka America Pharmaceutical, Inc.16$372
Janssen Pharmaceuticals, Inc10$296
Teva Pharmaceuticals USA, Inc.13$281
E.R. Squibb & Sons, L.L.C.11$230
Alkermes, Inc.12$227
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$198
Neurocrine BioSciences, Inc.5$151
Lundbeck LLC6$127
Noven Therapeutics, LLC6$115

Products named: VRAYLAR, REXULTI, AUSTEDO XR, INVEGA SUSTENNA, COBENFY, ARISTADA, CAPLYTA, INGREZZA.

Industry payments across CA — which companies pay providers there.